ArticleFrontiers in bioinformatics2026
How AI-based techniques for brain tumour diagnosis can address data variability.
Article in Frontiers in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Data variability in medical imaging of tumors refers to the inconsistencies in Magnetic Resonance Imaging and Computational Tomography scans caused by heterogeneous tumor biology, varying scanner hardware, and subjective human interpretation. This variability creates significant challenges for accurate diagnoses, treatment tracking, and AI model development. Although the variability in medical imaging data for diagnostic and prognostic purposes is a challenge for AI methods applied to other types of tumors as well, it is particularly problematic when the analysis involves gliomas and glioblastomas. Most gliomas are infiltrative and glioblastomas are highly infiltrative tumors with poorly defined margins. They exhibit significant regional variations, including cystic necrosis, localized hemorrhages, and complex microvascular proliferation. Addressing this variability requires a combination of algorithmic innovation, standardized datasets, and a leading-edge computational pipeline including traditional and AI-based data modelling methodologies to ensure diagnostic and prognostic models are robust. In this article, we will identify some AI methods that show promise in the analysis of brain tumor images and that must overcome the challenges posed by data availability. We will also offer some insights into how these challenges can be overcome and propose a possible computational pipeline that utilizes them.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.